With Merck’s COVID Antiviral Announcement, Can the Pharma Pipeline Build Treatment Momentum?

 

At the start of the month, pharmaceutical company Merck dropped big news: It has developed a COVID antiviral drug that would cut hospitalization and mortality risks by 50%. In the drug’s study, patients taking the placebo pill saw 14% hospitalization rate and eight deaths, while the trial group with Merck’s drug had only 7% hospitalized and zero deaths.

This appears to be just the tip of the iceberg; Kaiser Health News reports at least three COVID antiviral candidates, including Merck’s, going through late-stage clinical trials, meaning a variety of COVID drugs could be on patient’s prescriptions here soon. What’ll be some of the positive domino effects to come from approval of COVID antivirals, not only on the pharmaceutical production pipeline, but on the general population’s health? Ira Leiderman, managing director of the healthcare practice at Cassel Salpeter & Co., gave MarketScale his take on the coming treatments.

Follow us on social media for the latest updates in B2B!

Image

Latest

NBA
Slow Stories in a Fast League: Why the NBA Still Deserves Real, In-Depth Journalism
November 3, 2025

In a sports world increasingly defined by short-form clips, social algorithms, and viral takes, long-form storytelling remains a vital counterweight — the place where depth, nuance, and narrative still matter. The NBA, perhaps more than any other league, sits at the center of this tension: every quote can become a meme, every story a highlight…

Read More
skate
The Faith-Fueled Story Behind Camp Arnold Skate Church’s Mission to Reach Youth Through Skateboarding
November 2, 2025

As faith-based outreach evolves to meet younger generations where they are, skate culture has become an unlikely — yet powerful — frontier for transformation. In cities like Dallas, skateparks are serving as modern-day meeting grounds where faith, mentorship, and authenticity intersect. With youth mental health challenges on the rise — the CDC reports that…

Read More
sepsis
The Answers You Wanted On Sepsis – Episode 3
October 31, 2025

In episode three of The Michael Rothman Podcast, Dr. Rothman continues his deep dive into sepsis—a condition often misunderstood yet responsible for a significant portion of hospital deaths. Through data from a major northeastern hospital, he challenges traditional thinking: labeling a patient as “septic” isn’t what determines survival—their overall sickness is. Using the…

Read More
costume contacts
A Spooky Warning About Costume Contacts
October 31, 2025

As we get into the Halloween spirit, many are looking for that perfect finishing touch for their costumes, and cosmetic contact lenses are a popular choice. However, Dr. Emily Eisenhower offers a timely warning: while they may look great, these lenses can pose serious vision risks. She cautions that improper lenses can lead to…

Read More